Rhenman & Partners Asset Management AB / GILD
Rhenman & Partners Asset Management AB’s Gilead Sciences Inc Position
Does Rhenman & Partners Asset Management AB own Gilead Sciences Inc (GILD)? Yes — 167.8K shares worth $23M (+2.88% of its 13F portfolio) as of Q1 2026, up from 126.2K shares the prior filed quarter.
Position Value
$23M
Q1 2026
Shares
167.8K
% of Portfolio
+2.88%
Quarters Held
25
currently held
Position History GILD
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 167.8K | $23M | +2.88% |
| Q4 2025 | 126.2K | $15M | +1.45% |
| Q3 2025 | 80.2K | $9M | +0.98% |
| Q2 2025 | 168.2K | $19M | +2.36% |
| Q1 2025 | 233.5K | $26M | +3.01% |
| Q4 2024 | 255.5K | $24M | +2.43% |
| Q3 2024 | 366.5K | $31M | +2.49% |
| Q2 2024 | 238.5K | $16M | +1.57% |
| Q1 2024 | 127.0K | $9M | +0.88% |
| Q4 2023 | 259.0K | $21M | +2.10% |
| Q3 2023 | 234.0K | $18M | +1.89% |
| Q2 2023 | 234.0K | $18M | +1.90% |
| Q1 2023 | 259.0K | $21M | +2.32% |
| Q4 2022 | 270.0K | $23M | +2.42% |
| Q3 2022 | 270.0K | $21M | +2.22% |
| Q2 2022 | 200.0K | $12M | +1.40% |
| Q1 2022 | 170.0K | $10M | +1.00% |
| Q4 2021 | 275.0K | $20M | +1.34% |
| Q3 2021 | 300.0K | $21M | +1.47% |
| Q2 2021 | 300.0K | $21M | +1.40% |
| Q1 2021 | 350.0K | $23M | +1.58% |
| Q4 2020 | 385.0K | $22M | +1.83% |
| Q3 2020 | 290.0K | $18M | +1.63% |
| Q2 2020 | 230.0K | $18M | +1.91% |
| Q4 2018 | 188.2K | $12M | +1.35% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Rhenman & Partners Asset Management AB’s full portfolio or all institutional holders of GILD.